Skip to content

Sign Up

or

Forgot Password?

Don't have an account?

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account?

Jim Cramer’s top stock picks amid trade war

Jim Cramer's top stock picks amid trade war

Summary:

⚈Jim Cramer sees TJX Companies as the top retail winner of the trade war.
⚈ He believes U.S. retailers like Macy’s and Kohl’s could benefit from tariffs.
⚈Skepticism remains due to Cramer’s history of controversial stock calls.

The former hedge fund manager and host of Mad Money, Jim Cramer, has been overwhelmingly bullish about the U.S. economy and equities in 2025, repeatedly voicing his confidence that America will win the escalating trade war with China.

The trend continued on Monday, April 28, after Chinese stores Shein and Temu both increased prices on their products in anticipation of tariff implementation.

Shein, in particular, found its price tags in the headlines as it bumped the cost of some products by nearly 400%.

Jim Cramer claims U.S. retailers can benefit from the trade war

In response, Cramer posed the question of whether the sudden drop in Chinese competitiveness in the U.S. could help save firms such as Kohl’s (NYSE: KSS) and Macy’s (NYSE: M). Both retailers have been under severe pressure, and KSS stock is down 49.96% year-to-date (YTD) and 71.49% in the last 12 months.

Kohl's performance in the stock market in the last 12 months.
KSS stock 12-month price chart. Source: Finbold

M shares are likewise down 31.04% in 2025 and 38.47% in the last 12 months.

In the first hour of the April 28 session, Macy’s stock reacted positively to the news and soared 2.06%, while Kohl’s opened in the red.

Jim Cramer reveals ‘the real winner’ in the retailer trade war

Within the same X post, Jim Cramer also revealed the American store he would bet on: TJX Companies (NYSE: TJX).

TJX, which the former hedge fund manager called ‘the real winner,’ is also up 0.62% at the start of the Monday session. Furthermore, unlike both KSS and M, TJX shares are up 4.71% year-to-date and 33.86% in the one-year chart.

TJX shares performance in the last 12 months.
TJX stock 12-month price chart. Source: Finbold

Jim Cramer’s latest stock pick came after the famed host also opined that China’s refusal to back down in the trade war is part of Beijing’s strategy of having American consumers turn against President Donald Trump.

In the former hedge fund manager’s opinion, things are not ‘going to play out the way the PRC wants it to.’

Could Jim Cramer be wrong with his stock pick?

Still, it is worth pointing out that despite Cramer not being as frequently and catastrophically wrong as the popular joke would imply, the ‘inverse Jim Cramer’ meme and trading strategy are popular for a reason.

A good example of this came earlier in the trade war, when he opined that Beijing would not ban advanced Nvidia (NASDAQ: NVDA) hardware due to environmental concerns and that, even if it did, it would have no replacement.

The statement, rooted in China’s reputation for pollution, shows a lack of awareness in the East Asian country’s heavy investments in a green transition and came mere weeks before Huawei revealed its competing highly advanced chip.

Featured image via Shutterstock

Latest posts

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Stocks
Services

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.